DuPont Microbiome Venture signs agreement with BioMe Oxford to develop BioCapture ingestible capsule that samples gut health to assess the impact of probiotics and other nutrients on microbiome. Product should help shape future of precision medicine, firms say.
A DuPont de Nemours Inc.-owned research venture is partnering with British startup BioMe Oxford Ltd. in the early stages of developing an orally delivered capsule that can sample gut health to assess the impact of probiotics and other ingredients that effect the microbiome.
The platform technology, BioCapture, has potential to impact both research and healthcare applications through improved sampling of gastrointestinal biomarkers, says...
“RRAs are valuable oversight tools and under certain circumstances, can assist FDA in its mission to protect public health, oversee regulated industry, and help ensure regulated products comply with FDA requirements,” according to final guidance.
The European Commission’s Simplification Omnibus published July 8 is ‘step in right direction’ for streamlining processes and providing more legal certainty and predictability for regulations addressing cosmetics, says Cosmetics Europe.
Joshi joins the parent company of Citeline, home of HBW Insight, to focus on AI, business harmonization and long-term growth.
